Financial Architects (New Jersey)’s AbbVie ABBV Stock Holding History

Financial Architects (New Jersey)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-600	Closed	-$45K	–	897
2019 Q3	$45K	Buy	+600	New	+$41.1K	0.01%	457
2019 Q2	–	Sell	-200	Closed	-$16K	–	1179
2019 Q1	$16K	Buy	+200	New	+$16.4K	﹤0.01%	954
2018 Q4	–	Sell	-600	Closed	-$57K	–	1315
2018 Q3	$57K	Buy	+600	New	+$56.9K	0.01%	592
2018 Q2	–	Sell	-1,400	Closed	-$133K	–	1313
2018 Q1	$133K	Buy	+1,400	New	+$154K	0.03%	388
2016 Q3	–	Sell	-1,600	Closed	-$2K	–	1444
2016 Q2	$2K	Buy	+1,600	New	+$97.5K	﹤0.01%	1276

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Architects (New Jersey)'s ABBV Position: Q2 2023 in Review

Financial Architects (New Jersey) reduced its AbbVie (ABBV) stake by 1.2% in Q2 2023, selling an estimated $39.9K and leaving 23,278 shares worth $3.14M. The position accounts for 0.47% of the portfolio, ranked #47.

Financial Architects (New Jersey) first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $4.13M in Q1 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Financial Architects (New Jersey) held 23,278 shares of AbbVie worth $3.14M as of Q2 2023.
Financial Architects (New Jersey) sold 272 AbbVie shares in Q2 2023, an estimated $39.9K.
AbbVie made up 0.47% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #47 holding.
Financial Architects (New Jersey) first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
Financial Architects (New Jersey)'s AbbVie position peaked at $4.13M in Q1 2022.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.